Skip to main content
Top
Published in: BMC Infectious Diseases 1/2009

Open Access 01-12-2009 | Research article

Hyperglycemia in bacterial meningitis: a prospective cohort study

Authors: Ewout S Schut, Willeke F Westendorp, Jan de Gans, Nyika D Kruyt, Lodewijk Spanjaard, Johannes B Reitsma, Diederik van de Beek

Published in: BMC Infectious Diseases | Issue 1/2009

Login to get access

Abstract

Background

Hyperglycemia has been associated with unfavorable outcome in several disorders, but few data are available in bacterial meningitis. We assessed the incidence and significance of hyperglycemia in adults with bacterial meningitis.

Methods

We collected data prospectively between October 1998 and April 2002, on 696 episodes of community-acquired bacterial meningitis, confirmed by culture of CSF in patients >16 years. Patients were dichotomized according to blood glucose level on admission. A cutoff random non-fasting blood glucose level of 7.8 mmol/L (140 mg/dL) was used to define hyperglycemia, and a cutoff random non-fasting blood glucose level of 11.1 mmol/L (200 mg/dL) was used to define severe hyperglycemia. Unfavorable outcome was defined on the Glasgow outcome scale as a score <5. We also evaluated characteristics of patients with a preadmission diagnosis of diabetes mellitus.

Results

69% of patients were hyperglycemic and 25% severely hyperglycemic on admission. Compared with non-hyperglycemic patients, hyperglycemia was related with advanced age (median, 55 yrs vs. 44 yrs, P < 0.0001), preadmission diagnosis of diabetes (9% vs. 3%, P = 0.005), and distant focus of infection (37% vs. 28%, P = 0.02). They were more often admitted in coma (16% vs. 8%; P = 0.004) and with pneumococcal meningitis (55% vs. 42%, P = 0.007). These differences remained significant after exclusion of patients with known diabetes. Hyperglycemia was related with unfavorable outcome in a univariate analysis but this relation did not remain robust in a multivariate analysis. Factors predictive for neurologic compromise were related with higher blood glucose levels, whereas factors predictive for systemic compromise were related with lower blood glucose levels. Only a minority of severely hyperglycemic patients were known diabetics (19%). The vast majority of these known diabetic patients had meningitis due to Streptococcus pneumoniae (67%) or Listeria monocytogenes (13%) and they were at high risk for unfavorable outcome (52%).

Conclusion

The majority of patients with bacterial meningitis have hyperglycemic blood glucose levels on admission. Hyperglycemia can be explained by a physical stress reaction, the central nervous system insult leading to disturbed blood-glucose regulation mechanisms, and preponderance of diabetics for pneumococcal meningitis. Patients with diabetes and bacterial meningitis are at high risk for unfavorable outcome.
Literature
1.
go back to reference Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001, 32: 2426-2432. 10.1161/hs1001.096194.CrossRefPubMed Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001, 32: 2426-2432. 10.1161/hs1001.096194.CrossRefPubMed
2.
go back to reference Jeremitsky E, Omert LA, Dunham CM, Wilberger J, Rodriguez A: The impact of hyperglycemia on patients with severe brain injury. J Trauma. 2005, 58: 47-50. 10.1097/01.TA.0000135158.42242.B1.CrossRefPubMed Jeremitsky E, Omert LA, Dunham CM, Wilberger J, Rodriguez A: The impact of hyperglycemia on patients with severe brain injury. J Trauma. 2005, 58: 47-50. 10.1097/01.TA.0000135158.42242.B1.CrossRefPubMed
3.
go back to reference Kruyt ND, Roos YW, Dorhout Mees SM, Bergh van den WM, Algra A, Rinkel GJ, et al: High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2008, 79: 1382-1385. 10.1136/jnnp.2007.142034.CrossRefPubMed Kruyt ND, Roos YW, Dorhout Mees SM, Bergh van den WM, Algra A, Rinkel GJ, et al: High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2008, 79: 1382-1385. 10.1136/jnnp.2007.142034.CrossRefPubMed
4.
go back to reference Rovlias A, Kotsou S: The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery. 2000, 46: 335-342. 10.1097/00006123-200002000-00015.CrossRefPubMed Rovlias A, Kotsou S: The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery. 2000, 46: 335-342. 10.1097/00006123-200002000-00015.CrossRefPubMed
5.
go back to reference Powers WJ: Hyperglycemia is not associated with mortality in bacterial meningitis. Ann Neurol. 1983, 14: 82-83. 10.1002/ana.410140114.PubMed Powers WJ: Hyperglycemia is not associated with mortality in bacterial meningitis. Ann Neurol. 1983, 14: 82-83. 10.1002/ana.410140114.PubMed
6.
go back to reference Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002, 106: 2067-2072. 10.1161/01.CIR.0000034509.14906.AE.CrossRefPubMed Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002, 106: 2067-2072. 10.1161/01.CIR.0000034509.14906.AE.CrossRefPubMed
7.
go back to reference Berghe van den G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001, 345: 1359-1367. 10.1056/NEJMoa011300.CrossRefPubMed Berghe van den G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001, 345: 1359-1367. 10.1056/NEJMoa011300.CrossRefPubMed
8.
go back to reference van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al: Intensive insulin therapy in the medical ICU. N Engl J Med. 2006, 354: 449-461. 10.1056/NEJMoa052521.CrossRefPubMed van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al: Intensive insulin therapy in the medical ICU. N Engl J Med. 2006, 354: 449-461. 10.1056/NEJMoa052521.CrossRefPubMed
9.
go back to reference Hansen TK, Thiel S, Wouters PJ, Christiansen JS, van den Berghe G: Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003, 88: 1082-1088. 10.1210/jc.2002-021478.CrossRefPubMed Hansen TK, Thiel S, Wouters PJ, Christiansen JS, van den Berghe G: Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003, 88: 1082-1088. 10.1210/jc.2002-021478.CrossRefPubMed
10.
go back to reference Beek van de D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M: Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004, 351: 1849-1859. 10.1056/NEJMoa040845.CrossRefPubMed Beek van de D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M: Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004, 351: 1849-1859. 10.1056/NEJMoa040845.CrossRefPubMed
11.
go back to reference Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J: Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 2006, 5: 123-129. 10.1016/S1474-4422(05)70288-X.CrossRefPubMed Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J: Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 2006, 5: 123-129. 10.1016/S1474-4422(05)70288-X.CrossRefPubMed
12.
go back to reference Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet. 1975, 1: 480-484. 10.1016/S0140-6736(75)92830-5.CrossRefPubMed Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet. 1975, 1: 480-484. 10.1016/S0140-6736(75)92830-5.CrossRefPubMed
13.
go back to reference [Anon]: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008, 31: S55-S60. 10.2337/dc08-S055.CrossRef [Anon]: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008, 31: S55-S60. 10.2337/dc08-S055.CrossRef
14.
go back to reference van de Beek D, de Gans J, Tunkel AR, Wijdicks EF: Community-acquired bacterial meningitis in adults. N Engl J Med. 2006, 354: 44-53. 10.1056/NEJMra052116.CrossRefPubMed van de Beek D, de Gans J, Tunkel AR, Wijdicks EF: Community-acquired bacterial meningitis in adults. N Engl J Med. 2006, 354: 44-53. 10.1056/NEJMra052116.CrossRefPubMed
15.
go back to reference Little RJA, Rubin DB: Statistical analysis with missing data. 2002, Hoboken, N.J: Wiley, 2 Little RJA, Rubin DB: Statistical analysis with missing data. 2002, Hoboken, N.J: Wiley, 2
16.
go back to reference Allport LE, Butcher KS, Baird TA, Macgregor L, Desmond PM, Tress BM, et al: Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke. 2004, 35: 1886-1891. 10.1161/01.STR.0000133687.33868.71.CrossRefPubMed Allport LE, Butcher KS, Baird TA, Macgregor L, Desmond PM, Tress BM, et al: Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke. 2004, 35: 1886-1891. 10.1161/01.STR.0000133687.33868.71.CrossRefPubMed
17.
go back to reference Mitchell AJ: Clinical implications of poststroke hypothalamo-pituitary adrenal axis dysfunction: A critical literature review. J Stroke Cerebrovasc Dis. 1997, 6: 377-388. 10.1016/S1052-3057(97)80038-9.CrossRefPubMed Mitchell AJ: Clinical implications of poststroke hypothalamo-pituitary adrenal axis dysfunction: A critical literature review. J Stroke Cerebrovasc Dis. 1997, 6: 377-388. 10.1016/S1052-3057(97)80038-9.CrossRefPubMed
18.
go back to reference Huang CR, Lu CH, Chang HW, Lee PY, Lin MW, Chang WN: Community-acquired spontaneous bacterial meningitis in adult diabetic patients: an analysis of clinical characteristics and prognostic factors. Infection. 2002, 30: 346-350. 10.1007/s15010-002-3010-4.CrossRefPubMed Huang CR, Lu CH, Chang HW, Lee PY, Lin MW, Chang WN: Community-acquired spontaneous bacterial meningitis in adult diabetic patients: an analysis of clinical characteristics and prognostic factors. Infection. 2002, 30: 346-350. 10.1007/s15010-002-3010-4.CrossRefPubMed
19.
go back to reference Bruno A, Biller J, Adams HP, Clarke WR, Woolson RF, Williams LS, et al: Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999, 52: 280-284.CrossRefPubMed Bruno A, Biller J, Adams HP, Clarke WR, Woolson RF, Williams LS, et al: Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999, 52: 280-284.CrossRefPubMed
20.
go back to reference Prevention of Pneumococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1997, 46: 1-24. Prevention of Pneumococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1997, 46: 1-24.
21.
go back to reference The Pneumococcal Immunisation Programme For Older People And Risk Groups. 2005, London, United Kingdom, Department of Health The Pneumococcal Immunisation Programme For Older People And Risk Groups. 2005, London, United Kingdom, Department of Health
22.
go back to reference Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiologisches Bulletin. 2008, Berlin, Germany, Robert Koch-Institut, 30: 235-254. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiologisches Bulletin. 2008, Berlin, Germany, Robert Koch-Institut, 30: 235-254.
23.
go back to reference Weisfelt M, de Gans J, van der Poll T, van de Beek D: Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol. 2006, 5: 332-342. 10.1016/S1474-4422(06)70409-4.CrossRefPubMed Weisfelt M, de Gans J, van der Poll T, van de Beek D: Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol. 2006, 5: 332-342. 10.1016/S1474-4422(06)70409-4.CrossRefPubMed
24.
go back to reference Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Hjuler T, Kaltoft M, et al: Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000–2005. Vaccine. 2008, 26: 3765-3771. 10.1016/j.vaccine.2008.04.040.CrossRefPubMed Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Hjuler T, Kaltoft M, et al: Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000–2005. Vaccine. 2008, 26: 3765-3771. 10.1016/j.vaccine.2008.04.040.CrossRefPubMed
25.
go back to reference Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS, et al: Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993, 328: 21-28. 10.1056/NEJM199301073280104.CrossRefPubMed Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS, et al: Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993, 328: 21-28. 10.1056/NEJM199301073280104.CrossRefPubMed
26.
go back to reference Sigurdardottir B, Bjornsson OM, Jonsdottir KE, Erlendsdottir H, Gudmundsson S: Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med. 1997, 157: 425-430. 10.1001/archinte.157.4.425.CrossRefPubMed Sigurdardottir B, Bjornsson OM, Jonsdottir KE, Erlendsdottir H, Gudmundsson S: Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med. 1997, 157: 425-430. 10.1001/archinte.157.4.425.CrossRefPubMed
27.
go back to reference Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, et al: Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003, 34: 2208-2214. 10.1161/01.STR.0000085087.41330.FF.CrossRefPubMed Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, et al: Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003, 34: 2208-2214. 10.1161/01.STR.0000085087.41330.FF.CrossRefPubMed
28.
go back to reference Merz TM, Finfer S: Pro/con debate: Is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients?. Crit Care. 2008, 12: 212-10.1186/cc6837.CrossRefPubMedPubMedCentral Merz TM, Finfer S: Pro/con debate: Is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients?. Crit Care. 2008, 12: 212-10.1186/cc6837.CrossRefPubMedPubMedCentral
29.
go back to reference Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al: Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009, 360: 1283-97. 10.1056/NEJMoa0810625.CrossRefPubMed Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al: Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009, 360: 1283-97. 10.1056/NEJMoa0810625.CrossRefPubMed
Metadata
Title
Hyperglycemia in bacterial meningitis: a prospective cohort study
Authors
Ewout S Schut
Willeke F Westendorp
Jan de Gans
Nyika D Kruyt
Lodewijk Spanjaard
Johannes B Reitsma
Diederik van de Beek
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2009
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-9-57

Other articles of this Issue 1/2009

BMC Infectious Diseases 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.